This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Levodopa |
| Description |
A dopaminergic agent used in the treatment of Parkinson’s disease. Therapeutic levels vary widely from individual to individual. |
| Therapeutic Low |
1.0000 |
| Therapeutic High |
1.5000 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
1.00 |
| Half Life High |
2.00 |
| VOD Low |
0.90 |
| VOD High |
1.60 |
| Toxic Level |
0.000 |
| Lethal Level |
0.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
Warnings - may impair mental and/or physical ability required for the performance of potentially hazardous tasks (e.g., driving, operating heavy machinery). |